﻿Besides, in squamous cell carcinoma (SCC), a predominant histologic subtype accounting for approximately 80% of cervical cancer, the expression of PD-L1 is as high as 41–88%, which further ﻿provides a rationale to support the addition of immunotherapy in cervical cancer treatment [12–14]. The gene discussed is CD274; the disease is cervical carcinoma.